Search research articles
Contact Us
Filters
Showing results (251-260 of 487) with videos related to
Page
of 49
Sort By:
Journal of Computer Assisted Tomography
|
December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors
Payel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Journal of Hematology & Oncology
|
January 16, 2014
Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
Vivek Subbiah, Shannon N Westin, Kai Wang, et al.
The Oncologist
|
September 13, 2021
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial
Lori J Wirth, Bruce Robinson, Valentina Boni, et al.
Cell Reports. Medicine
|
December 20, 2023
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers
Mirella Nardo, Mohamed A Gouda, Blessie E Nelson, et al.
Nature Medicine
|
May 20, 2025
Cancer treatment paradigms in the precision medicine era
Vivek Subbiah, Giuseppe Curigliano, Jason K Sicklick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases
Vivek Subbiah, Jenny Berry, Michael Roxas, et al.
JAMA Network Open
|
November 3, 2022
Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non-Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment
Sreeram V Ramagopalan, Sanjay Popat, Alind Gupta, et al.
British Journal of Cancer
|
January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
Rachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
Healthcare (Basel, Switzerland)
|
December 17, 2024
Understanding the Landscape of Cancer Care in Europe: Evaluating Clinical and Comprehensive Cancer Centers
Denis Horgan, Marc Van den Bulcke, Núria Malats, et al.
CA: a Cancer Journal for Clinicians
|
January 4, 2024
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance
Raffaella Casolino, Philip A Beer, Debyani Chakravarty, et al.
Page
of 49
Search research articles
Search
Showing results (251-260 of 487) with videos related to
Sort By:
Page
of 49
Journal of Computer Assisted Tomography
|
December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors
Payel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Journal of Hematology & Oncology
|
January 16, 2014
Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
Vivek Subbiah, Shannon N Westin, Kai Wang, et al.
The Oncologist
|
September 13, 2021
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial
Lori J Wirth, Bruce Robinson, Valentina Boni, et al.
Cell Reports. Medicine
|
December 20, 2023
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers
Mirella Nardo, Mohamed A Gouda, Blessie E Nelson, et al.
Nature Medicine
|
May 20, 2025
Cancer treatment paradigms in the precision medicine era
Vivek Subbiah, Giuseppe Curigliano, Jason K Sicklick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases
Vivek Subbiah, Jenny Berry, Michael Roxas, et al.
JAMA Network Open
|
November 3, 2022
Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non-Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment
Sreeram V Ramagopalan, Sanjay Popat, Alind Gupta, et al.
British Journal of Cancer
|
January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
Rachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
Healthcare (Basel, Switzerland)
|
December 17, 2024
Understanding the Landscape of Cancer Care in Europe: Evaluating Clinical and Comprehensive Cancer Centers
Denis Horgan, Marc Van den Bulcke, Núria Malats, et al.
CA: a Cancer Journal for Clinicians
|
January 4, 2024
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance
Raffaella Casolino, Philip A Beer, Debyani Chakravarty, et al.
Page
of 49